Salivary mucins in patients with salivary gland tumors

Completed

• Conditions: salivary gland neoplasia; salivary gland tumor; 10027655

• Registration Number: NL-OMON33922
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 130

Inclusion Criteria

patients with a salivary gland tumor

Exclusion Criteria

none

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Expression and glycosylation and sialylation of mucines in salivary gland<br /><br>tumors, correlated to the presence of these mucins in saliva.<br /><br>Mucin in saliva of patients with salivary gland tumors, in comparison with<br /><br>normal controls.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>none</p><br>